Equities are best bet in long term – BarCap

Barclays Capital has published its fiftieth annual Equity Gilt study, in which it argues that historical experience continues to support equity investment for long-term investors, despite UK institutional investors’ shift to asset and liability matching strategies.

Pension funds and insurers have been moving out of equities and into long-dated gilts and high-rated corporate paper, spurred on by the introduction of the Financial Services Authority’s new prudential capital regime in 2002.

But the effect of adopting this asset/liability matching philosophy has been to depress long-term real and nominal bond yields, while cheapening equities relative to bonds.

The study notes that last year’s corporate bond returns, at 3.3%, were significantly weaker than the 10-year average of 8.5%. Gilts returned 3.6%, down from a 10-year average of 6.5%, while equities returned 8.8%, up from a 10-year average of 5%

Changes to pensions regulations in Europe could tip European institutional investors’ long-term strategies in the same direction, bringing further pressure on the long end of the fixed-income markets. There are two major regulatory drivers. Solvency II is the capital supervisory model for the insurance industry. The EU Pensions Directive, meanwhile, is “explicit in encouraging a move to asset and liability management”, according to the report.

The changes to EU policy are themselves driven by Europe’s burgeoning elderly population, which is rendering purely state-funded pension provision impossible.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here